Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026

Get updates on Theralase Technologies Inc. delivered in your email.

Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Level ll Quote ! looks good

View:

Post by knoxt on Feb 09, 2022 10:23am

Level ll Quote ! looks good

THERALASE TECHNOLOGIES INC (CA: TLT)

Real-time

Last:

0.440

Change:

0.005

Volume:

119,310

Last Trade:

10:17

Level ll Quote
Bid			Ask
Price	Total Size	# of Orders	Price	Total Size	# of Orders
$0.44	24500	3	$0.445	3500	1
$0.435	34000	7	$0.45	9000	2
$0.43	291500	2	$0.455	2000	1
$0.425	1000	1	$0.46	32500	3
$0.41	7500	1	$0.465	18000	3
$0.405	40000	2	$0.47	168500	2
$0.40	15000	3	$0.475	2500	1
$0.395	40000	1	$0.48	39500	5
$0.385	15000	1	$0.49	35500	5
$0.38	1000	1	$0.495	40500	3

571

Comment

Comment by StevenBirch on Feb 09, 2022 10:41am

TD sure likes to sell this stock, I would hope that being part of that big bid or exercising warrants is part of their strategy. It's funny with all the numbers being thrown around here that anybody would waste their time playing for nickels and dimes? But I guess that's what makes a market.

490

Comment

Theralase Technologies Inc.

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

Connect with V.TLT

INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

FACT SHEET

The Watchlist

< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250

Become a member today, It's free!

Sign In

Send my password